๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Pretransplant treatments for hepatocellular carcinoma: Do they improve outcomes?

โœ Scribed by Adrian M. Di Bisceglie

Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
62 KB
Volume
11
Category
Article
ISSN
1527-6465

No coin nor oath required. For personal study only.

โœฆ Synopsis

Key Points 1. Locoregional ablative treatments are commonly performed for heptocellular carcinoma (HCC) in patients awaiting transplantation, either to prevent the patient becoming untransplantable due to tumor growth or to prevent tumor recurrence post-operatively. 2. Although these treatments are quite effective at tumor destruction, there is no clear evidence that they improve patient outcomes. 3. Prospective, randomized controlled trials are clearly needed to determine if pre-transplant therapy of HCC is of value. (Liver Transpl 2005;11:

๐Ÿ“œ SIMILAR VOLUMES

The National Cancer Data Base report on
The National Cancer Data Base report on treatment patterns for hepatocellular carcinomas : Improved survival of surgically resected patients, 1985โ€“1996
โœ William G. Cance; Andrew K. Stewart; Herman R. Menck ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 109 KB ๐Ÿ‘ 3 views

The Commission on Cancer data from the National Cancer Data Base (NCDB) has previously reported data evaluating time trends in various cancers, including such elements as stage of disease at diagnosis, treatment, and survival for multiple tumor sites. In this report, data collected from 1985, 1986,